Microcrystalline Tyrosine (MCT(®)): A Depot Adjuvant in Licensed Allergy Immunotherapy Offers New Opportunities in Malaria

Microcrystalline Tyrosine (MCT(®)) is a widely used proprietary depot excipient in specific immunotherapy for allergy. In the current study we assessed the potential of MCT to serve as an adjuvant in the development of a vaccine against malaria. To this end, we formulated the circumsporozoite protei...

Full description

Saved in:
Bibliographic Details
Published in:Vaccines (Basel)
Main Authors: Cabral-Miranda, Gustavo, Heath, Matthew D., Gomes, Ariane C., Mohsen, Mona O., Montoya-Diaz, Eduardo, Salman, Ahmed M., Atcheson, Erwan, Skinner, Murray A., Kramer, Matthias F., Reyes-Sandoval, Arturo, Bachmann, Martin F.
Format: Artigo
Language:Inglês
Published: MDPI 2017
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5748599/
https://ncbi.nlm.nih.gov/pubmed/28953265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines5040032
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items